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Background: An ovotesticular disorder of sex development (OT-DSD) was rarely found in human. The mechanism
causing such condition is poorly understood. We hereby reported a 11-year-old child with OT-DSD and a karyotype
46,XX/46,XY, a single maternal and double paternal genetic contribution to the patient.
Results: Fluorescence in situ hybridization (FISH), blood grouping, HLA (human leukocyte antigen) haplotyping and
a genome-wide scanning of lymphocytes with 398 short tandem repeat microsatellite markers were performed to
investigate the origin of the cell lines concerned. ABO typing revealed that two populations of red cells were in the
patient, which were group A and group B, both from paternal alleles. HLA haplotyping showed the patient had
three haplotypes. Haplotype 1 was inherited from maternity, haplotype 2 and 3 were from paternity. The STR
microsatellite analysis showed 25 of the 74 fully informative markers in both parents, three alleles were inherited:
one of them was from mother, another two were from father. Seventeen of the thirty-eight paternal markers, the
patient inherited two paternal alleles. For 121 informative maternal markers, the patient had a single maternal allele.
There were two distinct alleles in locus DXS6810 and DXS1073 on X-chromosome, in which one was from the
mother and the other from the father.
Conclusions: The patient was a single maternal and double paternal genetic, which was a type of a
parthenogenetic division of a maternal haploid nucleus into two identical nuclei, followed by fertilization by two
spermatozoa and fusion of the two zygotes into a single individual at the early embryonic stage. To the best of our
knowledge, this is the oldest OT-DSD case of parthenogenetic chimerism. These data provide additional evidence
that a parthenogenetic maternal and double paternal contribution causes 46,XX/46,XY OT-DSD.
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Ovotesticular disorder of sex development (OT-DSD),
replaced the terminology ‘true hermaphrodite’ in 2006,
is a rare condition of sexual differentiation and defined
as the presence of ovarian and testicular tissue in the
same individual [1,2]. It constitutes 3%-10% of the total
DSD, and presents significant diagnostic and therapeutic
challenges [3]. Few cases of OT-DSD with such studies
have been reported [4-7]. The mechanism causing such* Correspondence: cuiyingxia55@gmail.com
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unless otherwise stated.46,XX/46,XY chimerism is poorly understood [8]. We
hereby report an 11-year–old child with an OT-DSD
and a 46,XX/46,XY karyotype in the cultures from
peripheral lymphocytes, skin fibroblasts and two kinds
of gonadal tissues.Case presentation
A 2-month-old infant was referred to our center because
of ambiguous genitalia. The initial physiological exami-
nation found the infant had a 1.0 cm phallus, but both
testes were unpalpable. The urethral meatus was located
between the phallus and the vaginal orifice. A 46, XY
karyotype was found at that moment. When the patient. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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breasts developed symmetrically and normally as female
at the age. The phallus length was 2.0-2.5 cm in droo-
ping and 4.5-5.5 cm during erection, but both testes
were still not palpable. In other respects the patient was
developing as normal girls. The blood concentrations
of gonadotrophins, prolactin, testosterone and proges-
terone were within the normal range for female children
(23 IU/L, 75 mIU/L, 0.6 nmol/L and 6 IU/L). Normal
uterus and Fallopian tube were found at laparoscopy.
Bilateral gonads demonstrated ovotestis (Figure 1A).
There were two kinds of tissue found at the position of
both ovaries: a yellow tissue in the middle and white tis-
sues at both poles. The white tissues showed ovarian
structure (Figure 1B) and the yellow tissue, testicular
structure (Figure 1C) through histopathological exami-
nation. Both the epididymides and vasa deferentia were
also absent. During the follow-up visiting, the patient
told us she had first menstruation at 11 years old and six
months after her menstrual cycle became regular about
28 days long.
Materials and methods
Cytogenetic analysis and fluorescent in situ hybridization
Chromosomes were prepared from phytohemagglutinin-
stimulated lymphocytes and cultured fibroblasts, fromFigure 1 Pathological analysis. (A): An ovotestis with a Fallopian tube. (B)
by pathological analysis. Ovarian foci contain oocytes (arrow) in primary and t
an ovotestis demonstrated by pathological analysis. Arrow indicates seminiferthe patient’s dermatic, ovarian and testicular tissues,
respectively. G-banding was according to standard tech-
niques. Fifty G-banding metaphases were analyzed for
each sample. Fluorescence in situ hybridization (FISH)
using a mixture of probes specific for DXZ1 and DYZ3
(CEPX Spectrum green, CEPY Spectrum orange; Vysis,
Downers Grove, IL) to determine X/Y-chromosome. FISH
was performed on 500 metaphases for each sample from
the patient. Tests were performed according to the ma-
nufacturer’s instructed protocols. Signals were visualized
under an Olympus BX51 microscope (Center Valley,
Pennsylvania) equipped with a cooled, charged coupled
device camera and Cytovision 3.0 image analysis software
(Applied Imaging, Sunderland, United Kingdom).
Short tandem-repeat (STR) microsatellite markers
DNA was isolated from the peripheral blood of the
patient and the parents. Using two commercial kits
(PRISM Human Linkage Mapping Set v2.5, ABI, USA
and PowerPlex 16, Promega, USA) with a total of 379
short- tandem-repeat (STR) microsatellite markers
distributed over all 22 autosomes and 19 markers over
X-chromosome. PCR products were analyzed in the
ABI 377 DNA Sequencer (Applied Biosystems, USA).
The results were analyzed by GeneMapper Software
v4.0 (ABI).: Ovarian tissue from the middle position of an ovotestis demonstrated
ertiaryfollicles (HE staining). (C): Testicular tissue from the both polars of
ous tubules (HE staining).
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Red cell typing for ABO (DiaMed-ID micro typing system,
DiaMed, Switzerland) [9] and other blood-group antigens
for the patient and the parents were assessed. Genomic
samples of blood from the patient and the parents
were also used for molecular typing of HLA class I and
II markers by polymerase chain reaction (ABDR003vl-
20020412 kits, Pel-Freez Clinical Systems, USA) sequence-
specific primer amplification [10].
Results
Chromosome analysis on peripheral lymphocyte and fi-
broblasts from the cultures of testicular tissue (Figure 2A),
ovarian tissue (Figure 2B), skin tissue (Figure 2C) and pa-
tient’s blood (Figure 2D) revealed 46,XX/46,XY karyotype
ratios of 23:27, 13:37, 44:6 and 5:45 (in 50 metaphases),
respectively. The results of FISH were consistent with
those of the cytogenetic analysis. The STR microsatellite
analysis showed 25 of the 74 fully informative markers in
both parents, the patient inherited three alleles, both pa-
ternal alleles and a single maternal allele and they dis-
tributed over 14 autosomes. For all 42 markers, 17 of the
38 only informative markers in the father, the patient
showed three alleles and two of them originating from the
father. For a total of 146 markers, 25 fully informa-
tive markers and 121 informative maternal markers, the
patient was inherited a single maternal allele. For 4Figure 2 FISH analysis. (A): FISH showed the predomination of XY
cells over the interphase nuclei of the cultured-fibroblasts from the
testicular tissues of the patient. (B): FISH showed the predomination of
XX cells over the interphase nuclei of the cultured-fibroblasts from the
ovarian tissue of the patient. (C): FISH showed the predomination XY
cells interphase nuclei of the cultured-fibroblasts from the patient’s
skin. (D): FISH showed the predomination of XY cells over the
interphase nuclei of the lymphocytes from the patient’s blood.X-chromosomal fully informative markers, the patient was
showed two distinct alleles, in which one from the mother
and the other from the father. None of 379 loci in auto-
somes showed 4 alleles. The ABO typing revealed that
there were two populations of red cells in the patient,
group A and group B. The mother was group O and the
father group AB. The other blood groups the patient had
such as Kidd, P, MNSs and Rh were the same as those of
the parents. HLA haplotyping showed that the patient had
three haplotypes, haplotype 1 was inherited from mater-
nity, haplotype 2 and haplotype 3 from paternity. All de-
tails were shown in Table 1.
Discussion
We presented the clinical, cytogenetic, and molecular
genetic findings of an OT-DSD of parthenogenetic chi-
mera, to possess a single maternal genetic contribution
and two paternal genetic contributions. As to the origin of
a 46,XX/46,XY individual, four mechanisms have been
identified by analysis of polymorphic microsatellite marker
loci: (1) fusion of two distinct embryos [11], such a
chimera showed two paternal and two maternal haploid
genomes (Figure 3A). (2) A 47,XXY zygote during early
embryonic development involved two separate non-dis-
junction events, resulting in the loss of X and Y, respec-
tively [12]. Such a mosaic revealed a 46,XX/46,XY and a
paternal and a maternal haploid genome, but two distinct
alleles on X-chromosomal marker locus were identified,
which implied that the two X-chromosomes in patient’s
karyotype originated differently (Figure 3B-1 and B-2). (3)
Fertilization of one parthenogenetic ovum by a spermato-
zoon and was diploidization of the other [13] (Figure 3C).
Such a chimera also presented a paternal and a maternal
haploid genome. This mechanism can be distinguished
from the second by comparison of X-chromosomal
marker locus and such a chimera had a single allele, which
suggested the two X-chromosomes in patient’s karyotype
originated identically. (4) A single haploid ovum divided
parthenogenetically into two haploid ova, followed by
double fertilization and fusion of the two zygotes into a
single individual [14]. Such a chimera identified one single
maternal allele and two paternal alleles (Figure 3D). The
parthenogenetic phenomenon was also found in the IVF
(in-vitro fertilization) laboratory [15] and induced by
exposing tubal ova to high or low temperature, to a hyper-
tonic or hypotonic solution or to stimulation with an elec-
tric current or to ether anesthesia.
Although no case of parthenogenesis has been reported
in humans, it is possible that some individuals are partly
parthenogenetic. For the first time, Strain et al. [15]
described a ‘parthenogenetic chimera’ where one of the
clones contained cells derived exclusively from a single
duplicated maternal genome. Molecular studies using
microsatellite markers showed a double paternal and a
Table 1 Results of HLA haplotyping on the patient and the parents
Haplotype 1 Haplotype 2 Haplotype 3
Mother HLA-A*02, B*51, DRB1*09 HLA-A*0203, B*38, DRB1*16
Father HLA-A*24, B*46, DRB1*04 HLA-A*24, B*54, DRB1*09
Patient HLA-A*02, B*51, DRB1*09 HLA-A*24, B*46, DRB1*04 HLA-A*24, B*54, DRB1*09
*Indicates an allele.
Figure 3 Proposed mechanisms to explain chimera. (A): Fusion of two distinct embryos. (B-1, B-2): Double mitotic nondisjunction of a 47,
XXY zygote or sequential nondisjunction events in a 47,XXY single lineage. (C): Fertilization of one parthenogenetic ovum by a spermatozoon,
and the diploidization of the other. (D): Parthenogenetic division of two identical ova, which were fertilized by two spermatozoa respectively.
Xia et al. Molecular Cytogenetics 2014, 7:16 Page 4 of 6
http://www.molecularcytogenetics.org/content/7/1/16
Xia et al. Molecular Cytogenetics 2014, 7:16 Page 5 of 6
http://www.molecularcytogenetics.org/content/7/1/16single maternal allelic contribution. In 1998, Giltay et al.
[7] reported another patient with ambiguous genitalia. A
parthenogenetic activation of the oocyte taking place be-
fore fertilization was suggested. In 2005, Chen et al. [16]
presented the prenatal diagnosis, sonographic findings
and, molecular genetic analysis of a 46,XX/46,XY true
hermaphrodite chimera. Informative sex chromosome and
pericentromeric autosome markers demonstrated double
paternal and single maternal genetic contributions. In
2007, Souter et al. [10] reported a rare case of 46,XX/46,
XY twins, twin A presented with ambiguous genitalia and
twin B was a phenotypically normal male. The twins are
chimeric and share a single genetic contribution from
their mother but have two genetic contributions from
their father thus supporting the existence of a third, pre-
viously unreported type of twinning. In 2008, Hersmus
et al. [17] experienced two late-diagnosed children who
presented with proximal hypospadias and bilateral scrotal
gonads. One should consider the possibility of ovotesticu-
lar DSD when managing patients with proximal hypospa-
dias even if both gonads are palpable in the scrotum.
The present case demonstrated that only a single ma-
ternal genetic contributes to the patient’s genome. First,
an allele revealed in locus DXS6810 and locus DXS1073,
which implied only a maternal X chromosomal contri-
bution to the patient’s genome. Second, HLA haplo-
typing presented a single maternal allele and third, 146
marker loci on autosomes clearly demonstrated that the
patient was inherited one maternal allele. These results
are compatible with the involvement of one maternal
gamete. With respect to the paternal genetic contribu-
tion, there were a number of evidences to identify two
different spermatozoa from the father. For example, both
a paternal X chromosome and a Y chromosome contrib-
uted to the patient karyotype; the ABO typing revealed
two populations of red cells, group A and group B, both
from paternal alleles; HLA haplotyping and 42 inform-
ative marker loci demonstrated the inheritance of the
two paternal alleles, so the possibility of the first three
mechanisms can be ruled out. It is very likely that in the
present case there may be a parthenogenetic division of
a haploid nucleus to give two identical nuclei followed
by fertilization by two spermatozoa, just as the mode of
origin of the chimerism described by Giltay et al. [7]. To
the best of our knowledge, this is the oldest OT-DSD
case of parthenogenetic chimerism.
Conclusion
We presented the clinical, cytogenetic, and molecular
genetic findings of an OT-DSD of parthenogenetic chi-
mera, to possess a single maternal genetic contribution
and two paternal genetic contributions. These data pro-
vide additional evidence that a parthenogenetic maternal
and double paternal contribution causes 46,XX/46,XYOT-DSD. The mechanism causing such parthenogenetic
chimera need to be further investigated.
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